Table II.
Pathways associated with the proteins regulated in lung tissue from Bufei Yishen formula-treated rats.
| Term | Count | % | P-value |
|---|---|---|---|
| Focal adhesion | 13 | 0.5527 | 8.96×10−5 |
| Tight junction | 10 | 0.4252 | 3.02×10−4 |
| Hypertrophic cardiomyopathy | 8 | 0.3401 | 4.79×10−4 |
| Regulation of actin cytoskeleton | 12 | 0.5102 | 6.92×10−4 |
| Glycolysis/Gluconeogenesis | 7 | 0.2976 | 0.002728022 |
| Leukocyte transendothelial migration | 8 | 0.3401 | 0.003040578 |
| Dilated cardiomyopathy | 7 | 0.2976 | 0.003855419 |
| Adherens junction | 6 | 0.2551 | 0.007806313 |
| Extracellular matrix-receptor interaction | 6 | 0.2551 | 0.011328586 |
| Glyoxylate and dicarboxylate metabolism | 3 | 0.1276 | 0.016548236 |
| Metabolism of xenobiotics by cytochrome P450 | 5 | 0.2126 | 0.017848404 |
| Prion diseases | 4 | 0.1701 | 0.020435392 |
| Pyruvate metabolism | 4 | 0.1701 | 0.027198439 |
| Drug metabolism | 5 | 0.2126 | 0.032368833 |
| Fatty acid metabolism | 4 | 0.1701 | 0.032961744 |
| Tryptophan metabolism | 4 | 0.1701 | 0.035013439 |
| Valine, leucine and isoleucine degradation | 4 | 0.1701 | 0.041555659 |
| Cardiac muscle contraction | 5 | 0.2126 | 0.041625416 |